NASH or MASH? Name changes to established condition stir up confusion in liver disease community

27 Jul 2023

It’s a literal mish-MASH of medical terminology as a global group of liver disease societies voted last month to change the name of NASH (nonalcoholic steatohepatitis) to MASH (metabolic dysfunction-associated steatohepatitis). So far, the new names have gained little traction. Verywell Health, a health news and information source, has updated its health directory with the new nomenclature, but competitors WebMD and MayoClinic.org have not. Organizations with NASH in their titles — such as the Global Liver Institute’s NASH Council and Genfit’s NASH Education Program — haven’t mentioned any upcoming changes. (Neither group responded to requests for comment.)

For more details,please visit the original website

The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.

Organizations

Global Liver Institute

Genfit SA

Indications

Nonalcoholic SteatohepatitisLiver DiseasesMetabolic dysfunction-associated steatotic liver disease

Targets

Drugs

Hot reports

Global Drug R&D Express (Apr 2024)

PatSnap Synapse

Global Drug R&D Express (Mar 2024)

PatSnap Synapse

Global Drug R&D Express (Feb 2024)

PatSnap Synapse

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.